Breastcancer.org Podcasts: Experts discuss research & issues
Comments
-
Exercise As Cancer Treatment
January 6, 2026
Dr. Kerry Courneya discusses the CHALLENGE trial, the first study to show exercise improved survival after cancer treatment.
The CHALLENGE trial found that a three-year, structured exercise program after chemotherapy for stage III colon cancer reduced the risk of the cancer coming back (recurrence risk) and also led to people living longer overall. Dr. Kerry Courneya, the lead researcher, thinks the results can be applied to people with other types of cancer, including breast cancer.
Listen to the episode to hear Dr. Courneya explain:
- why the study asked people to exercise for three years
- why he thinks the results may spur insurance companies to cover exercise-related costs, like equipment and gym memberships
- the reasons why the results also could apply to people diagnosed with breast cancer
0 -
AIMSS: How Aromatase Inhibitors Can Affect Hands and Wrists
January 13, 2026
If you’re taking an aromatase inhibitor, you may have pain in your hands and wrists. Dr. David Bozentka explains the syndrome.
Bone and joint pain are some of the most common side effects of aromatase inhibitors, medicines for hormone receptor-positive breast cancer. The official name for this is aromatase inhibitor associated — or sometimes induced — musculoskeletal syndrome, also called AIMSS. Many people report pain in the knees, ankles, and hips while taking an aromatase inhibitor, but the hands and the wrists also might be affected.
Hand expert Dr. David Bozentka discusses how AIMSS can affect the wrists and hands, including symptoms such as carpal tunnel syndrome, trigger finger, and tendonitis.
Listen to the episode to hear Dr. Bozentka explain:
- the theories why aromatase inhibitors cause joint and bone pain, or AIMSS
- how to decrease the risk of AIMSS
- how carpal tunnel syndrome, trigger finger, and tendonitis are treated
0 -
How Will Health Insurance Changes Affect People With Metastatic Breast Cancer?
February 3, 2026
Triage Cancer CEO Joanna Doran answers questions about Medicare, Medicaid, and metastatic breast cancer.
The changes to federal- and state-run health insurance programs can be confusing, especially since some of the changes haven’t been implemented yet and others are being challenged in court. How will these changes affect people with metastatic breast cancer?
This podcast is the audio from a special Virtual Support Group featuring guest moderator Joanna Doran.
Listen to the episode to hear Joanna explain:
- what short-term health insurance plans are and what they may not cover
- what Medigap plans are and how they’re purchased
- Medicaid work requirements and required documentation
- differences between Medicare parts A, B, C, and D
0
